Noninvasive Optical Tracking of Red Fluorescent Protein-Expressing Cancer Cells in a Model of Metastatic Breast Cancer

We have evaluated the use of the Xenogen IVIS 200 imaging system for real-time fluorescence protein- based optical imaging of metastatic progression in live animals. We found that green fluorescent protein- expressing cells (100 × 106) were not detectable in a mouse cadaver phantom experiment. Howev...

Full description

Bibliographic Details
Main Authors: Paul T. Winnard, Jr., Jessica B. Kluth, Venu Raman
Format: Article
Language:English
Published: Elsevier 2006-10-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558606800837
_version_ 1819203606510829568
author Paul T. Winnard, Jr.
Jessica B. Kluth
Venu Raman
author_facet Paul T. Winnard, Jr.
Jessica B. Kluth
Venu Raman
author_sort Paul T. Winnard, Jr.
collection DOAJ
description We have evaluated the use of the Xenogen IVIS 200 imaging system for real-time fluorescence protein- based optical imaging of metastatic progression in live animals. We found that green fluorescent protein- expressing cells (100 × 106) were not detectable in a mouse cadaver phantom experiment. However, a 10-fold lower number of tdTomato-expressing cells were easily detected. Mammary fat pad xenografts of stable MDA-MB-231-tdTomato cells were generated for the imaging of metastatic progression. At 2 weeks postinjection, barely palpable tumor burdens were easily detected at the sites of injection. At 8 weeks, a small contralateral mammary fat pad metastasis was imaged and, by 13 weeks, metastases to lymph nodes were detectable. Metastases with nodular composition were detectable within the rib cage region at 15 weeks. 3-D image reconstructions indicated that the detection of fluorescence extended to approximately 1 cm below the surface. A combination of intense tdTomato fluorescence, imaging at ≥ 620 nm (where autofluorescence is minimized), the sensitivity of the Xenogen imager made this possible. This study demonstrates the utility of the noninvasive optical tracking of cancer cells during metastatic progression with endogenously expressed fluorescence protein reporters using detection wavelengths of ≥ 620 nm.
first_indexed 2024-12-23T04:22:35Z
format Article
id doaj.art-27be1a3801f944678792717555cb2057
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-12-23T04:22:35Z
publishDate 2006-10-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-27be1a3801f944678792717555cb20572022-12-21T18:00:13ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022006-10-0181079680610.1593/neo.06304Noninvasive Optical Tracking of Red Fluorescent Protein-Expressing Cancer Cells in a Model of Metastatic Breast CancerPaul T. Winnard, Jr.Jessica B. KluthVenu RamanWe have evaluated the use of the Xenogen IVIS 200 imaging system for real-time fluorescence protein- based optical imaging of metastatic progression in live animals. We found that green fluorescent protein- expressing cells (100 × 106) were not detectable in a mouse cadaver phantom experiment. However, a 10-fold lower number of tdTomato-expressing cells were easily detected. Mammary fat pad xenografts of stable MDA-MB-231-tdTomato cells were generated for the imaging of metastatic progression. At 2 weeks postinjection, barely palpable tumor burdens were easily detected at the sites of injection. At 8 weeks, a small contralateral mammary fat pad metastasis was imaged and, by 13 weeks, metastases to lymph nodes were detectable. Metastases with nodular composition were detectable within the rib cage region at 15 weeks. 3-D image reconstructions indicated that the detection of fluorescence extended to approximately 1 cm below the surface. A combination of intense tdTomato fluorescence, imaging at ≥ 620 nm (where autofluorescence is minimized), the sensitivity of the Xenogen imager made this possible. This study demonstrates the utility of the noninvasive optical tracking of cancer cells during metastatic progression with endogenously expressed fluorescence protein reporters using detection wavelengths of ≥ 620 nm.http://www.sciencedirect.com/science/article/pii/S1476558606800837Breast canceroptical imagingtdTomatoXenogenmetastasis
spellingShingle Paul T. Winnard, Jr.
Jessica B. Kluth
Venu Raman
Noninvasive Optical Tracking of Red Fluorescent Protein-Expressing Cancer Cells in a Model of Metastatic Breast Cancer
Neoplasia: An International Journal for Oncology Research
Breast cancer
optical imaging
tdTomato
Xenogen
metastasis
title Noninvasive Optical Tracking of Red Fluorescent Protein-Expressing Cancer Cells in a Model of Metastatic Breast Cancer
title_full Noninvasive Optical Tracking of Red Fluorescent Protein-Expressing Cancer Cells in a Model of Metastatic Breast Cancer
title_fullStr Noninvasive Optical Tracking of Red Fluorescent Protein-Expressing Cancer Cells in a Model of Metastatic Breast Cancer
title_full_unstemmed Noninvasive Optical Tracking of Red Fluorescent Protein-Expressing Cancer Cells in a Model of Metastatic Breast Cancer
title_short Noninvasive Optical Tracking of Red Fluorescent Protein-Expressing Cancer Cells in a Model of Metastatic Breast Cancer
title_sort noninvasive optical tracking of red fluorescent protein expressing cancer cells in a model of metastatic breast cancer
topic Breast cancer
optical imaging
tdTomato
Xenogen
metastasis
url http://www.sciencedirect.com/science/article/pii/S1476558606800837
work_keys_str_mv AT paultwinnardjr noninvasiveopticaltrackingofredfluorescentproteinexpressingcancercellsinamodelofmetastaticbreastcancer
AT jessicabkluth noninvasiveopticaltrackingofredfluorescentproteinexpressingcancercellsinamodelofmetastaticbreastcancer
AT venuraman noninvasiveopticaltrackingofredfluorescentproteinexpressingcancercellsinamodelofmetastaticbreastcancer